Perea, AD, Sala, NJ, Martínez, AR, Pagès, MB, García, JR, Marcos, CA, Molinero, VR, Fernandez, JPA, Franco, PG, Aguilar, NT, Bargalló, HV, Rey, EMA, Martin, AR, Arnal, CF, Gomez, MVM, Parreño, IA, Moreno, SG, González, JMR, Rull, FJC, Martin, DM, Deulofeu, AM, Martínez, SB, Errasti, AM, Pardo, GS, de Fez, PC. CBCT dose optimisation in prostate IGRT. RADIOTHERAPY AND ONCOLOGY. 2025; 206DOI:. PMID:. IF:5.300(Q1/2D).

Bargalló, HV, Aguilar, NT, Sala, NJ, Fernández, JPA, Marco, CA, Franco, PG, Rey, EMA, Pagès, MB, Martínez, AR, Perea, AD, Molinero, VR, García, JR, Bernardó, NF, de Fez, PC. Dosimetric Impact of Different CT Image Sets on Lung SBRT Planning. RADIOTHERAPY AND ONCOLOGY. 2025; 206DOI:. PMID:. IF:5.300(Q1/2D).

Gomis-Sellés, E, Maldonado, A, Gaztañaga, M, Vera, V, Ajulia, O, Sancho, G, Siva, S, Lopez-Campos, F, Couñago, F. Impact of PSMA-PET/CT on Radiotherapy Decisions: Is There a Clinical Benefit?. Cancers. 2025; 17(8)DOI:10.3390/cancers17081350. PMID:40282526. IF:4.400(Q2/3D).

Otero-Pla, E, Raspall, MJF, Franco, PG, Martínez, JF, Saladich, IG, Sala, NJ, Gisbert, ML, Cordero, JR, Verdum, JI, Sancho-Pardo, G. Mapping clinical and imaging factors that might predict cardiac events in breast cancer patients. Frontiers in Oncology. 2025; 15DOI:10.3389/fonc.2025.1552908. PMID:40134591. IF:3.300(Q2/4D).